Injury Notes: Crowder, Thompson, Rose, Anderson

Jae Crowder‘s status for Boston’s game against Cleveland on Wednesday night isn’t yet known, but an MRI on his injured left elbow confirmed that there’s no structural damage, which is good news for the Celtics forward, writes Chris Forsberg of Crowder referred to himself as day-to-day, and there’s a chance he’ll play through the injury.

Meanwhile, on the other side of tonight’s matchup, there’s some some good news and bad news for the Cavaliers. In the positive column, Kyle Korver returned to the team’s lineup on Tuesday night after missing 11 games with a foot injury. However, another key rotation player, Tristan Thompson, left that game with what has since been diagnosed as a sprained right thumb.

Thompson has appeared in 447 consecutive games, but that streak will come to an end this week, as he has officially been ruled out for the Cavaliers’ next two games against Boston and Atlanta. The veteran big man will continue to undergo treatment and be re-evaluated, with the team presumably hoping he can return in time for the playoffs.

Here are a few more injury updates of note from around the NBA:

  • The Knicks announced today (via Twitter) that point guard Derrick Rose underwent an “uncomplicated” left knee arthroscopy to address his meniscus tear. The team expects Rose to resume basketball activities in about three to six weeks.
  • Rockets forward Ryan Anderson, who has been sidelined with a sprained ankle for nearly two weeks, may return later this week. As Mark Berman of FOX 26 Houston tweets, James Harden suggested today that the club is hoping to get Anderson back on Friday.
  • Dirk Nowitzki has a chance to return to the lineup for the Mavericks on Wednesday night, per head coach Rick Carlisle. Nowitzki will be a game-time decision after having sat out the team’s last game with Achilles soreness, tweets Earl K. Sneed of
  • Colin Hoobler, a physical therapist in Portland, took a closer look at Trail Blazers center Jusuf Nurkic‘s fibular fracture in an interesting piece for The Oregonian.
View Comments (2)